Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort-Reference-Cited by-同舟云学术

Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort

Published:2021-11 Issue:11 Volume:9 Page:1241-1254
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Radicioni Giorgia,Ceppe Agathe,Ford Amina A,Alexis Neil E,Barr R Graham,Bleecker Eugene R,Christenson Stephanie A,Cooper Christopher B,Han MeiLan K,Hansel Nadia N,Hastie Annette T,Hoffman Eric A,Kanner Richard E,Martinez Fernando J,Ozkan Esin,Paine Robert,Woodruff Prescott G,O'Neal Wanda K,Boucher Richard C,Kesimer Mehmet

Funder

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference40 articles.

1. The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease;Hogg;Physiol Rev,2017

2. Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998–2009;Akinbami;NCHS Data Brief,2011

3. Chronic respiratory symptoms with normal spirometry. A reliable clinical entity?;Rodriguez-Roisin;Am J Respir Crit Care Med,2017

4. At the root: defining and halting progression of early chronic obstructive pulmonary disease;Martinez;Am J Respir Crit Care Med,2018

5. Clinical significance of symptoms in smokers with preserved pulmonary function;Woodruff;N Engl J Med,2016

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 in patients with airways disease: COPD, asthma and bronchiectasis;COVID-19: An Update;2024-09-01

2. Chemical profiling and mechanisms of Agarikon pill in a rat model of cigarette smoke-induced chronic obstructive pulmonary disease;Journal of Traditional and Complementary Medicine;2024-09

3. It is high time to discard a cut-off of 0.70 in the diagnosis of COPD;Expert Review of Respiratory Medicine;2024-08-27

4. A first-in-kind MAPK13 inhibitor that can correct stem cell reprogramming and post-injury disease;2024-08-22

5. Dysregulated Airway Host Defense in Hyper IgE Syndrome due to STAT3 Mutations;2024-08-15